Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

PHCY525 Core Clinical Pharmacy

Medication in the treatment of diseases including cardiovascular, endocrine, mental health, infectious diseases, and respiratory.

Want to be able to confidently recommend and discuss evidence-based pharmacotherapy for your patients? The vast array of medications available to treat diseases makes it very important that pharmacists have a depth of understanding of pharmacotherapy in order to serve as knowledge navigators for patients and other health professionals. This unique depth of knowledge enables pharmacists to optimise medicines therapy and reduce drug-related morbidity and mortality. PHCY 525, along with the other applied clinical pharmacy papers, helps pharmacists become active members of the health care team, contributing to optimising medicines-related health outcomes and being recognised as having this specialised knowledge.

Paper title Core Clinical Pharmacy
Paper code PHCY525
Subject Pharmacy
EFTS 0.2500
Points 30 points
Teaching period Not offered in 2017
Domestic Tuition Fees (NZD) $2,692.75
International Tuition Fees (NZD) $9,125.00

^ Top of page

Restriction
PHCX 522, PHCY 522, PHCX 523, PHCY 523, PHCX 525
Limited to
PGDipClinPharm
Notes
May not be offered if fewer than five students enrol.
Eligibility
This paper is targeted at pharmacists who wish to spend the majority of their time providing clinical pharmacy services and applying the skills gained to the optimal care of patients as part of a high-functioning health care team.
Contact
linda@cpsl.biz (first semester)
murphy@pharmacy.arizona.edu (second semester)
Teaching staff
Paper Co-ordinators: Dr Linda Bryant (first semester) and Professor John Murphy (second semester)
Professional Practice Fellow: Mr Keith Crump (second semester)
Paper Structure
This paper involves studying specific disease areas and the use of evidence-based pharmacotherapy in the treatment of diseases and preparation of patient-centric care plans for actual patients, which includes information gathering, patient assessment, evaluation of all aspects of pharmacotherapy, care planning, communication of the plan, and follow up. This paper runs parallel to other applied clinical pharmacy papers.
Teaching Arrangements
Two compulsory 2-day weekend workshops (February and July) and five 2-hour audioconferences.
Textbooks
Textbooks are not required for this paper.
Graduate Attributes Emphasised
Lifelong learning, Communication, Critical thinking, Self-motivation.
View more information about Otago's graduate attributes.
Learning Outcomes
Students who successfully complete the paper should be able to
  • Describe the pathophysiologic basis of the diseases and disorders covered
  • Discuss, in depth, the pharmacological basis of current therapeutics
  • Highlight and evaluate areas of therapeutic controversy and new drug developments
  • Fluently and confidently use clinical terminology
  • Quantify likely adverse effects and interactions in terms of the relevance to an individual
  • Apply pharmacotherapy knowledge and problem-solving skills to improve the medication management for specific patients, including accounting for all factors influencing the person's medicines use
  • Communicate clear and concise therapeutic information in oral and written form

^ Top of page

Timetable

Not offered in 2017

Location
Dunedin
Teaching method
This paper is taught through Distance Learning
Learning management system
Blackboard

Medication in the treatment of diseases including cardiovascular, endocrine, mental health, infectious diseases, and respiratory.

Want to be able to confidently recommend and discuss evidence-based pharmacotherapy for your patients? The vast array of medications available to treat diseases makes it very important that pharmacists have a depth of understanding of pharmacotherapy in order to serve as knowledge navigators for patients and other health professionals. This unique depth of knowledge enables pharmacists to optimise medicines therapy and reduce drug-related morbidity and mortality. PHCY 525, along with the other applied clinical pharmacy papers, helps pharmacists become active members of the health care team, contributing to optimising medicines-related health outcomes and being recognised as having this specialised knowledge.

Paper title Core Clinical Pharmacy
Paper code PHCY525
Subject Pharmacy
EFTS 0.2500
Points 30 points
Teaching period Not offered in 2018
Domestic Tuition Fees Tuition Fees for 2018 have not yet been set
International Tuition Fees Tuition Fees for international students are elsewhere on this website.

^ Top of page

Restriction
PHCX 522, PHCY 522, PHCX 523, PHCY 523, PHCX 525
Limited to
PGDipClinPharm
Notes
May not be offered if fewer than five students enrol.
Eligibility
This paper is targeted at pharmacists who wish to spend the majority of their time providing clinical pharmacy services and applying the skills gained to the optimal care of patients as part of a high-functioning health care team.
Contact
linda@cpsl.biz (first semester)
bruce.russell@otago.ac.nz (second semester)
Teaching staff
Paper Co-ordinators: Dr Linda Bryant (first semester) and Associate Professor Bruce Russell (second semester)
Paper Structure
This paper involves studying specific disease areas and the use of evidence-based pharmacotherapy in the treatment of diseases and preparation of patient-centric care plans for actual patients, which includes information gathering, patient assessment, evaluation of all aspects of pharmacotherapy, care planning, communication of the plan, and follow up. This paper runs parallel to other applied clinical pharmacy papers.
Teaching Arrangements
Two compulsory 2-day weekend workshops (February and July) and five 2-hour audioconferences.
Textbooks
Textbooks are not required for this paper.
Graduate Attributes Emphasised
Lifelong learning, Communication, Critical thinking, Self-motivation.
View more information about Otago's graduate attributes.
Learning Outcomes
Students who successfully complete the paper should be able to
  • Describe the pathophysiologic basis of the diseases and disorders covered
  • Discuss, in depth, the pharmacological basis of current therapeutics
  • Highlight and evaluate areas of therapeutic controversy and new drug developments
  • Fluently and confidently use clinical terminology
  • Quantify likely adverse effects and interactions in terms of the relevance to an individual
  • Apply pharmacotherapy knowledge and problem-solving skills to improve the medication management for specific patients, including accounting for all factors influencing the person's medicines use
  • Communicate clear and concise therapeutic information in oral and written form

^ Top of page

Timetable

Not offered in 2018

Location
Dunedin
Teaching method
This paper is taught through Distance Learning
Learning management system
Blackboard